Fast Market Research

Recently Released Market Study: Radius Health, Inc. - Product Pipeline Review - 2012

New Pharmaceuticals market report from Global Markets Direct: "Radius Health, Inc. - Product Pipeline Review - 2012"


Boston, MA -- (SBWIRE) -- 12/20/2012 -- Global Market Direct's pharmaceuticals report, "Radius Health, Inc. - Product Pipeline Review - 2012" provides data on the Radius Health, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Radius Health, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Radius Health, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Radius Health, Inc. - Brief Radius Health, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Radius Health, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Radius Health, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Radius Health, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get this Report

- Evaluate Radius Health, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Radius Health, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Radius Health, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Radius Health, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Radius Health, Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- OPKO Health, Inc. - Product Pipeline Review - 2012
- Eisai Co., Ltd. - Product Pipeline Review - 2012
- Other Male Health Disorders - Pipeline Review, H2 2012
- Post Menopausal Osteoporosis - Pipeline Review, H2 2012
- Karo Bio - Product Pipeline Review - 2012
- Post Menopausal Osteoporosis - Pipeline Review, H1 2012
- Brain Cancer - Pipeline Review, H1 2012
- Stroke - Pipeline Review, H1 2012
- Biogen Idec Inc. - Product Pipeline Review - 2012
- Emergent BioSolutions Inc. - Product Pipeline Review - 2012